Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00198172
Status:
TERMINATED
Last Update Posted:
2014-06-03
First Post:
2005-09-08
Brief Title:
Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors
Sponsor:
Organization:
Indiana University